woman skips breakfast

(Credit: Farknot Architect on Shutterstock)

In A Nutshell

  • Adults with Crohn’s disease who ate only during an 8-hour window (fasting 16 hours daily) saw stool frequency drop 40% and abdominal discomfort cut in half
  • Participants didn’t change what they ate or count calories, they just ate their regular foods in a shorter time window
  • The eating schedule reduced dangerous visceral belly fat while the control group gained it
  • All participants were in remission and stayed on their medications, showing this approach may help maintain symptom control

Adults with Crohn’s disease lost dangerous belly fat and reduced key symptoms by changing only when they ate, not what they ate, according to a study from Canadian researchers. Participants consumed their regular foods and didn’t count calories. They simply compressed all their meals into an 8-hour window each day, fasting for the remaining 16 hours, six days per week.

Around 40% of people with Crohn’s disease are overweight or obese, and excess body fat (especially the kind that wraps around internal organs) can make the disease worse. This visceral fat pumps out inflammatory chemicals that trigger more severe disease activity, reduce how well medications work, and increase the risk of needing surgery. Despite these risks, doctors rarely recommend specific eating schedules to address weight and inflammation in Crohn’s patients.

The study, published in Gastroenterology, measured calorie intake and diet quality throughout the 12-week trial and found no differences between the fasting group and controls. People weren’t eating less or eating healthier, they were eating the same foods in a shorter time window. Yet their bodies responded dramatically. During the 16-hour fast, the body runs through its ready supply of glucose and starts breaking down stored fat for fuel, which may trigger a cascade of anti-inflammatory effects.

How the Eating Schedule Worked

Researchers at the University of Calgary and University of British Columbia enrolled 35 adults with Crohn’s disease who were overweight and whose disease was quiet but not cured. Half followed a 16:8 fasting schedule: eating all their meals within an 8-hour window, such as between 10 a.m. and 6 p.m. The other half continued eating on their normal schedule with no time restrictions.

Participants in the fasting group kept their regular diets. A registered dietitian checked in at the start and around week four, and remained available throughout the study. Both groups stayed on their usual Crohn’s medications.

Adherence was remarkably high, 95% on average. Participants logged their eating windows daily, and researchers checked in every two weeks. At the beginning and end, researchers measured body weight, body composition using specialized scans, blood markers, stool samples, and disease activity.

Intermittent Fasting
Timing when you eat may be just as meaningful as what you eat. (Credit: Pormezz/Shutterstock)

The Changes Were Meaningful

Body mass index dropped significantly in the fasting group (nearly one full point) while the control group’s BMI actually increased slightly. Even more notable was what happened to visceral fat. Participants who followed the eating schedule lost substantial amounts of this dangerous internal fat, while the control group gained it.

Clinical symptoms improved markedly. Stool frequency dropped by 40%, and abdominal discomfort decreased by 50%. Disease severity scores fell by 2 points in the fasting group compared to just half a point in controls. For patients trying to avoid flare-ups, these changes could make a real difference in daily life.

Blood tests showed major changes in fat-related hormones. Leptin, a hormone produced by fat cells that also promotes inflammation, dropped dramatically. Two other proteins secreted by fat tissue also fell significantly. Scientists think these hormones connect excess body fat to immune system problems, so reducing them might help calm the inflammatory processes in Crohn’s disease.

Participants who lost more than one BMI unit showed increases in both pro-inflammatory and anti-inflammatory immune molecules. Researchers suggest this mixed immune signal may reflect a period of immune adjustment, though this remains speculative.

Gut Bacteria Showed Exploratory Shifts

In exploratory analyses, stool samples suggested that gut bacteria changed in the fasting group. Several bacteria known to produce beneficial compounds called short-chain fatty acids became more abundant. These compounds help maintain the intestinal barrier and have anti-inflammatory effects.

In Crohn’s disease, a leaky gut barrier allows bacteria and food particles to escape the intestine and trigger immune responses. Bacteria that produce these protective compounds might help repair this barrier. While these findings didn’t reach statistical significance after accounting for multiple comparisons, they align with other research showing that fasting can promote beneficial bacteria.

Why the Clock Matters as Much as the Calories

Other research suggests that extended fasting periods may influence the body’s internal daily rhythms: the natural cycles that coordinate when gut bacteria are active and when immune cells patrol the intestinal lining. Some studies indicate that eating around the clock disrupts these rhythms, leading to immune problems and bacterial overgrowth in the small intestine.

By consolidating food intake into a defined window, this eating pattern might restore normal daily cycles of gut function. In this study, traditional markers of active intestinal inflammation stayed stable in both groups, indicating the improvements reflected better symptom control and metabolic health rather than healing of existing damage.

What This Could Mean for Treatment

For people with Crohn’s disease who are overweight, this eating schedule offers a straightforward approach that doesn’t require special foods, supplements, or complicated meal planning. Participants simply stopped eating earlier in the evening and delayed breakfast. The high adherence rate suggests people can stick with this approach. Anyone considering this eating pattern should discuss it with their healthcare provider to ensure it’s appropriate for their individual situation.

Reducing visceral fat might have benefits beyond symptom control. This type of fat has been linked to worse responses to biologic medications, the expensive infused or injected drugs that many Crohn’s patients rely on to maintain remission. If meal timing can reduce this problematic fat, it might help medications work better.

This was a small study of 35 participants over 12 weeks, so larger and longer trials are needed to confirm these results and determine if people can maintain this eating pattern for years. All participants were in remission at the start, so it’s unclear whether this approach could help people with active disease. The study also lacked a calorie-matched control group, making it hard to know whether the benefits came from meal timing itself or from the modest weight loss.

Still, doctors treating inflammatory bowel disease have traditionally focused on medication management, sometimes overlooking how lifestyle factors influence disease progression. These findings suggest that metabolic health and immune function are deeply connected, and that simple behavioral changes might complement medical therapy. Patients shouldn’t abandon their medications, but they might consider adding this approach alongside their prescribed treatments.


Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read in this article.


Paper Notes

Study Limitations

This randomized controlled trial enrolled 35 participants (20 in the fasting group, 15 controls) over 12 weeks. The small sample size and short duration limit the ability to draw broad conclusions. The study lacked a calorie-matched control group, making it difficult to separate the effects of meal timing from modest weight loss. All participants were in clinical remission and on stable medications, so results may not apply to people with active disease. The study excluded participants with certain complications including upper gastrointestinal involvement, multiple surgeries, or ostomies. Gut bacteria findings were exploratory and did not survive statistical correction for multiple testing. Traditional inflammatory markers (C-reactive protein and fecal calprotectin) did not change significantly.

Funding and Disclosures

This work was funded by the Crohn’s & Colitis Foundation Litwin IBD Pioneers grant (ID: 879104) and Imagine Network (University of Calgary). Natasha Haskey was supported by a TRIANGLE (TRaIning A New generation of researchers in Gastroenterology and LivEr) postdoctoral fellowship and Michael Smith Health Research BC Health Professional Investigator Award. The authors disclosed no conflicts of interest.

Publication Details

Authors: Natasha Haskey, PhD, RD (Department of Biology, University of British Columbia, Kelowna, British Columbia, Canada); Jiayu Ye, PhD (Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo Alto, California); Ayva Lewis, BSc (Department of Biology, University of British Columbia, Kelowna, British Columbia, Canada, and Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada); Munazza Yousuf, MD (Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada); Raylene A. Reimer, PhD, RD (Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada); Maitreyi Raman, MD, MSc, FRCPC (Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada) | Journal: Gastroenterology (2025, in press) | Title: “Time-Restricted Feeding Reduces Body Mass Index, Visceral Adiposity, Systemic Inflammation, and Clinical Disease Activity in Adults With Crohn’s Disease: A Randomized Controlled Study” | DOI: https://doi.org/10.1053/j.gastro.2025.11.008 | Clinical Trial Registration: ClinicalTrials.gov, Number NCT05230160 | The study was conducted between May 2023 and January 2024 at outpatient clinics in Calgary, Alberta, and Kelowna, British Columbia, Canada. It received ethics approval from the University of British Columbia (H22-02645) and the University of Calgary (REB21-1539). The study adhered to ICH-GCP guidelines, the Declaration of Helsinki, and TCPS 2 guidelines. All participants provided written informed consent.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment

1 Comment